Brief: Biofrontera Inc. Announces Record Preliminary Fourth Quarter 2025 Revenues Between $17.0 Million And $17.5 Million, Representing Approximately 35% Year-Over-Year Growth
13/01/2026 13:36
Jan 13 (Reuters) - Biofrontera Inc BFRI.O: BIOFRONTERA INC. ANNOUNCES RECORD PRELIMINARY FOURTH QUARTER 2025 REVENUES BETWEEN $17.0 MILLION AND $17.5 MILLION, REPRESENTING APPROXIMATELY 35% YEAR-OVER-YEAR GROWTH Source text: ID:nGNX1yrwWp Further company coverage: BFRI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biofrontera
See all newsBrief: Biofrontera Submits Supplemental New Drug Application To FDA To Expand Ameluz® Red Light Pdt To Actinic Keratoses On The Full Body
Biofrontera Inc reports results for the quarter ended June 30 - Earnings Summary
Biofrontera Q2 revenue rises on higher volume, pricing
Biofrontera Inc expected to post a loss of 10 cents a share - Earnings Preview
Biofrontera Q1 revenue rises on higher Ameluz sales